\-\ Texto\\:\\ \ \(0\)\
\-\ by\\ report\\,\\ physical\\ exam\\ was\\ unremarkable\\.\\ \\ no\\ laboratory\\ analysis\\ was\\ available\\.\\ \\ patient\\ was\\ subsequently\\ medevaced\\ to\\ the\\ us\\ based\\ on\\ findings\\ on\\ cxr\\.\ \(0\)\
\-\ patient\\ has\\ undergone\\ orchiectomy\\.\\ \\ additional\\ treatment\\ is\\ likely\\ to\\ include\\ platinum\\-based\\ chemotherapy\\.\ \(0\)\
\-\ cxr\\ demonstrates\\ numerous\\ \\"cannonball\\"\\ masses\\ within\\ both\\ lungs\\.\\ \\ initial\\ ct\\ of\\ the\\ ab\\/pelv\\ performed\\ overseas\\ \\(currently\\ unavailable\\)\\ demonstrated\\ an\\ approximately\\ 10\\ cm\\ soft\\ tissue\\ density\\ mass\\ encasing\\ the\\ abdominal\\ aorta\\ and\\ vena\\ cava\\,\\ presumably\\ massive\\ paraortic\\ lymphadenopathy\\.\\ \\ scrotal\\ us\\ demonstrates\\ a\\ heterogeneous\\ mass\\ with\\ areas\\ of\\ calcification\\ in\\ the\\ right\\ testis\\.\ \(0\)\
\-\ metastatic\\ testicular\\ neoplasm\\,\\ most\\ likely\\ choriocarcinoma\\ or\\ mixed\\ nsgct\ \(0\)\
\-\ metastatic\\ ca\\,\\ testicular\\ primary\ \(0\)\
\-\ metastatic\\ ca\\,\\ with\\ met\\ to\\ testicle\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ 31\\ yo\\ active\\ duty\\ male\\ deployed\\ to\\ the\\ middle\\ east\\ presented\\ to\\ his\\ general\\ medical\\ officer\\ with\\ complaint\\ of\\ hemoptysis\\.\ \(0\)\
\-\ choriocarcinoma\\ accounts\\ for\\ only\\ 0\\.5\\%\\ of\\ primary\\ testicular\\ neoplasm\\,\\ but\\ up\\ to\\ 23\\%\\ of\\ mixed\\ nsgct\\ will\\ contain\\ a\\ component\\ of\\ choriocarcinoma\\.\\ \\ patients\\ with\\ choriocarcinoma\\ often\\ have\\ symptoms\\ related\\ to\\ hemorrhagic\\ metastases\\,\\ as\\ this\\ patient\\ with\\ hemoptysis\\.\ \(0\)\
\-\ ref\\:\\ \\ diagnostic\\ ultrasound\\,\\ 3rd\\ ed\\.\\,\\ rumack\\ c\\.m\\.\\,\\ wilson\\ s\\.r\\.\\,\\ charboneau\\ j\\.w\\.\\,\\ 2005\\ mosby\\ inc\\.\\,\\ 854\\-857\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.3920559224549773\ \(0\)\
\-\ nsgct\\:\\ 0\\.24041623501793027\ \(0\)\
\-\ testicular\\:\\ 0\\.2213193988408003\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.16282240911405557\ \(0\)\
\-\ to\\:\\ 0\\.13765940513592334\ \(0\)\
\-\ ca\\:\\ 0\\.13422922118037975\ \(0\)\
\-\ mixed\\:\\ 0\\.1302303905659499\ \(0\)\
\-\ metastatic\\:\\ 0\\.12942838394341222\ \(0\)\
\-\ cxr\\:\\ 0\\.12585832230627678\ \(0\)\
\-\ medevaced\\:\\ 0\\.1257994783474694\ \(0\)\
\-\ us\\:\\ 0\\.1251456215329132\ \(0\)\
\-\ cannonball\\:\\ 0\\.12020811750896514\ \(0\)\
\-\ overseas\\:\\ 0\\.12020811750896514\ \(0\)\
\-\ paraortic\\:\\ 0\\.12020811750896514\ \(0\)\
\-\ charboneau\\:\\ 0\\.12020811750896514\ \(0\)\
\-\ based\\:\\ 0\\.11396289985590463\ \(0\)\
\-\ east\\:\\ 0\\.11316383593969201\ \(0\)\
\-\ neoplasm\\:\\ 0\\.10739890054989912\ \(0\)\
\-\ rumack\\:\\ 0\\.10668248937258261\ \(0\)\
\-\ officer\\:\\ 0\\.10505826218301745\ \(0\)\
\-\ encasing\\:\\ 0\\.10109112853407833\ \(0\)\
\-\ primary\\:\\ 0\\.09673868407089571\ \(0\)\
\-\ ref\\:\\ 0\\.09628798179919171\ \(0\)\
\-\ met\\:\\ 0\\.0940468469648052\ \(0\)\
\-\ likely\\:\\ 0\\.09401429053481271\ \(0\)\
\-\ of\\:\\ 0\\.09236416438306375\ \(0\)\
\-\ wilson\\:\\ 0\\.09211953081433318\ \(0\)\
\-\ undergone\\:\\ 0\\.09153263404663493\ \(0\)\
\-\ presumably\\:\\ 0\\.09153263404663493\ \(0\)\
\-\ deployed\\:\\ 0\\.09096969904447119\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.08990840685706979\ \(0\)\
\-\ accounts\\:\\ 0\\.08756550039769581\ \(0\)\
\-\ unavailable\\:\\ 0\\.08714115945253313\ \(0\)\
\-\ testis\\:\\ 0\\.08519568662715973\ \(0\)\
\-\ scrotal\\:\\ 0\\.08317402580359401\ \(0\)\
\-\ was\\:\\ 0\\.08224464435320031\ \(0\)\
\-\ mosby\\:\\ 0\\.0816897997413434\ \(0\)\
\-\ massive\\:\\ 0\\.08087035121305776\ \(0\)\
\-\ testicle\\:\\ 0\\.07912876167599042\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0790390075627312\ \(0\)\
\-\ contain\\:\\ 0\\.07866905268734321\ \(0\)\
\-\ the\\:\\ 0\\.07848072911795057\ \(0\)\
\-\ with\\:\\ 0\\.07701612662439455\ \(0\)\
\-\ patient\\:\\ 0\\.07675550679590973\ \(0\)\
\-\ vena\\:\\ 0\\.07600494706951162\ \(0\)\
\-\ cava\\:\\ 0\\.07563719213971636\ \(0\)\
\-\ 2005\\:\\ 0\\.0747585515311221\ \(0\)\
\-\ duty\\:\\ 0\\.07458934704513612\ \(0\)\
\-\ analysis\\:\\ 0\\.07315325364115986\ \(0\)\
\-\ 3rd\\:\\ 0\\.0718527100695844\ \(0\)\
\-\ 31\\:\\ 0\\.0698059992979943\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.06823470880528036\ \(0\)\
\-\ complaint\\:\\ 0\\.06812903784685947\ \(0\)\
\-\ component\\:\\ 0\\.0674111810009421\ \(0\)\
\-\ subsequently\\:\\ 0\\.06711461059018987\ \(0\)\
\-\ numerous\\:\\ 0\\.06644645258206822\ \(0\)\
\-\ report\\:\\ 0\\.06626134923108011\ \(0\)\
\-\ 23\\:\\ 0\\.06486369908570552\ \(0\)\
\-\ aorta\\:\\ 0\\.06390121604542415\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.06359475915371646\ \(0\)\
\-\ metastases\\:\\ 0\\.06359475915371646\ \(0\)\
\-\ general\\:\\ 0\\.06314747694125075\ \(0\)\
\-\ additional\\:\\ 0\\.06097988890837319\ \(0\)\
\-\ currently\\:\\ 0\\.06042698664044275\ \(0\)\
\-\ mass\\:\\ 0\\.060094435503050124\ \(0\)\
\-\ diagnostic\\:\\ 0\\.05995346397746246\ \(0\)\
\-\ related\\:\\ 0\\.059780002663970724\ \(0\)\
\-\ active\\:\\ 0\\.05841353985023536\ \(0\)\
\-\ lungs\\:\\ 0\\.0580540038494181\ \(0\)\
\-\ laboratory\\:\\ 0\\.05712288698931257\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.056934624780769605\ \(0\)\
\-\ middle\\:\\ 0\\.05625068332970322\ \(0\)\
\-\ calcification\\:\\ 0\\.05616200139966669\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.05585603021644911\ \(0\)\
\-\ masses\\:\\ 0\\.053552355625912866\ \(0\)\
\-\ areas\\:\\ 0\\.05340681345597328\ \(0\)\
\-\ available\\:\\ 0\\.053370666665694996\ \(0\)\
\-\ initial\\:\\ 0\\.05277023924187076\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05273572109469759\ \(0\)\
\-\ density\\:\\ 0\\.052161758508903075\ \(0\)\
\-\ often\\:\\ 0\\.051327690826442667\ \(0\)\
\-\ will\\:\\ 0\\.0506296984355627\ \(0\)\
\-\ approximately\\:\\ 0\\.050192808909986786\ \(0\)\
\-\ medical\\:\\ 0\\.04999356922501301\ \(0\)\
\-\ yo\\:\\ 0\\.0491442645789084\ \(0\)\
\-\ only\\:\\ 0\\.0491442645789084\ \(0\)\
\-\ ultrasound\\:\\ 0\\.048520881940605255\ \(0\)\
\-\ demonstrated\\:\\ 0\\.04834424650059578\ \(0\)\
\-\ his\\:\\ 0\\.047707295258357055\ \(0\)\
\-\ on\\:\\ 0\\.04751523417898119\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04684876789378332\ \(0\)\
\-\ include\\:\\ 0\\.046803849311411024\ \(0\)\
\-\ performed\\:\\ 0\\.046537367732223466\ \(0\)\
\-\ 10\\:\\ 0\\.04599820630808814\ \(0\)\
\-\ presented\\:\\ 0\\.04587188488190944\ \(0\)\
\-\ cm\\:\\ 0\\.04517713092996928\ \(0\)\
\-\ patients\\:\\ 0\\.04425231568684741\ \(0\)\
\-\ both\\:\\ 0\\.04386642795681238\ \(0\)\
\-\ symptoms\\:\\ 0\\.043040011618467225\ \(0\)\
\-\ abdominal\\:\\ 0\\.043022955348394974\ \(0\)\
\-\ physical\\:\\ 0\\.04265295774224689\ \(0\)\
\-\ soft\\:\\ 0\\.041878579290031054\ \(0\)\
\-\ tissue\\:\\ 0\\.04126490773133853\ \(0\)\
\-\ most\\:\\ 0\\.04093867763891184\ \(0\)\
\-\ exam\\:\\ 0\\.0395990616516221\ \(0\)\
\-\ have\\:\\ 0\\.039296550875348564\ \(0\)\
\-\ up\\:\\ 0\\.038911688893867515\ \(0\)\
\-\ but\\:\\ 0\\.03889904332434735\ \(0\)\
\-\ findings\\:\\ 0\\.038823412462400314\ \(0\)\
\-\ treatment\\:\\ 0\\.037471425339384586\ \(0\)\
\-\ within\\:\\ 0\\.036229814425947325\ \(0\)\
\-\ has\\:\\ 0\\.03593102815019983\ \(0\)\
\-\ male\\:\\ 0\\.035023853868249785\ \(0\)\
\-\ by\\:\\ 0\\.03340492950228214\ \(0\)\
\-\ as\\:\\ 0\\.031601773231596186\ \(0\)\
\-\ an\\:\\ 0\\.03008051888481874\ \(0\)\
\-\ ct\\:\\ 0\\.029947794158655547\ \(0\)\
\-\ or\\:\\ 0\\.027365504062579957\ \(0\)\
\-\ this\\:\\ 0\\.0270300698936291\ \(0\)\
\-\ right\\:\\ 0\\.02608008410258594\ \(0\)\
\-\ no\\:\\ 0\\.02558035651084433\ \(0\)\
\-\ for\\:\\ 0\\.02384219259284084\ \(0\)\
\-\ is\\:\\ 0\\.021542434037807763\ \(0\)\
\-\ in\\:\\ 0\\.019568835118420964\ \(0\)\
\-\ and\\:\\ 0\\.01625477383900553\ \(0\)\
